Treatment Response Evaluation by F-18 FDG PET/CT in Radioiodine Refractory Differentiated Carcinoma in a Case with Multiple Unusual Metastatic Lesions

Koç Z. P., Özcan P. P., Güney İ. B.

molecular oncologic imaging, cilt.2, sa.3, ss.52-55, 2022 (Hakemli Dergi)

  • Yayın Türü: Makale / Vaka Takdimi
  • Cilt numarası: 2 Sayı: 3
  • Basım Tarihi: 2022
  • Dergi Adı: molecular oncologic imaging
  • Sayfa Sayıları: ss.52-55
  • Çukurova Üniversitesi Adresli: Evet

Özet

Abstract F-18 FDG PET/CT has a documented role in diagnosis of the patients with radioiodine refractory differentiated thyroid carcinoma (RAIR-DTC) and there are ongoing studies about the treatment response evaluation for tyrosine kinase inhibitor treatment response evaluation. This case report is about the treatment response evaluation of a unique patient with multiple unusual metastatic lesions of RAIR-DTC.